Surgery Partners, Inc.
SGRY
$13.97
$0.191.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 4.50% | 2.38% | 6.63% | 8.41% | 8.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.50% | 2.38% | 6.63% | 8.41% | 8.17% |
| Cost of Revenue | 5.96% | 6.66% | 5.62% | 8.18% | 9.25% |
| Gross Profit | -1.05% | -9.16% | 10.03% | 9.15% | 4.25% |
| SG&A Expenses | 9.17% | -34.17% | -23.29% | -10.42% | 8.43% |
| Depreciation & Amortization | 6.06% | 76.70% | -21.31% | 15.80% | 7.72% |
| Other Operating Expenses | -- | 47.31% | 22.73% | 67.69% | -- |
| Total Operating Expenses | 5.89% | 8.69% | 2.43% | 8.20% | 9.47% |
| Operating Income | -6.14% | -22.83% | 34.70% | 9.67% | -0.88% |
| Income Before Tax | -1,000.00% | -42.59% | 182.57% | 31.53% | -101.05% |
| Income Tax Expenses | -- | -88.74% | 22.22% | -122.45% | -- |
| Earnings from Continuing Operations | -600.00% | 162.23% | 295.31% | 58.10% | -101.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 9.63% | 28.92% | -25.98% | -7.97% | -1.91% |
| Net Income | 4.77% | 86.18% | 28.39% | 83.87% | -204.03% |
| EBIT | -6.14% | -22.83% | 34.70% | 9.67% | -0.88% |
| EBITDA | -2.62% | -6.52% | 16.01% | 11.14% | 1.45% |
| EPS Basic | 6.08% | 86.37% | 28.94% | 83.97% | -202.64% |
| Normalized Basic EPS | -28.53% | -92.64% | -107.41% | -149.70% | -106.71% |
| EPS Diluted | 6.67% | 86.37% | 28.34% | 83.73% | -200.00% |
| Normalized Diluted EPS | -28.53% | -92.64% | -107.41% | -149.70% | -106.71% |
| Average Basic Shares Outstanding | 1.39% | 1.44% | 0.82% | 0.67% | 0.50% |
| Average Diluted Shares Outstanding | 1.39% | 1.44% | 0.82% | 0.67% | 0.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |